Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi agents for inhibiting expression of complement component C3 (C3), pharmaceutical compositions thereof, and methods of use

RNAi agents for inhibiting expression of complement component C3 (C3), pharmaceutical compositions thereof, and methods of use

US Patent 12110492 · Granted Oct 8, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
Automobile and/or toy replica thereof2025
5′-cyclo-phosphonate modified nucleotides2025
RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), 2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there2025
Alpha-v beta-6 integrin ligands and uses thereof2024
Alpha-v beta-6 integrin ligands and uses thereof2024
Targeting ligands for therapeutic compounds2024
Intelligent load clusters for freight2024